25 XP   0   0   10

Biohit Oyj B
Buy, Hold or Sell?

Let's analyse Biohit Oyj B together

PenkeI guess you are interested in Biohit Oyj B. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biohit Oyj B. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biohit Oyj B

I send you an email if I find something interesting about Biohit Oyj B.

Quick analysis of Biohit Oyj B (30 sec.)










What can you expect buying and holding a share of Biohit Oyj B? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
€0.62
Expected worth in 1 year
€1.13
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
€0.51
Return On Investment
24.8%

For what price can you sell your share?

Current Price per Share
€2.05
Expected price per share
€1.885 - €2.09
How sure are you?
50%

1. Valuation of Biohit Oyj B (5 min.)




Live pricePrice per Share (EOD)

€2.05

Intrinsic Value Per Share

€-0.05 - €2.17

Total Value Per Share

€0.57 - €2.79

2. Growth of Biohit Oyj B (5 min.)




Is Biohit Oyj B growing?

Current yearPrevious yearGrowGrow %
How rich?$10m$7.9m$2m20.7%

How much money is Biohit Oyj B making?

Current yearPrevious yearGrowGrow %
Making money$2m$639.8k$1.3m68.4%
Net Profit Margin14.5%5.5%--

How much money comes from the company's main activities?

3. Financial Health of Biohit Oyj B (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#686 / 1016

Most Revenue
#271 / 1016

Most Profit
#139 / 1016

Most Efficient
#97 / 1016

What can you expect buying and holding a share of Biohit Oyj B? (5 min.)

Welcome investor! Biohit Oyj B's management wants to use your money to grow the business. In return you get a share of Biohit Oyj B.

What can you expect buying and holding a share of Biohit Oyj B?

First you should know what it really means to hold a share of Biohit Oyj B. And how you can make/lose money.

Speculation

The Price per Share of Biohit Oyj B is €2.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biohit Oyj B.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biohit Oyj B, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.62. Based on the TTM, the Book Value Change Per Share is €0.13 per quarter. Based on the YOY, the Book Value Change Per Share is €0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biohit Oyj B.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.136.5%0.136.5%0.042.1%-0.05-2.6%-0.05-2.5%
Usd Book Value Change Per Share0.146.6%0.146.6%0.010.5%-0.09-4.5%-0.11-5.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.073.6%
Usd Total Gains Per Share0.146.6%0.146.6%0.010.5%-0.09-4.5%-0.03-1.6%
Usd Price Per Share2.01-2.01-1.67-2.37-3.63-
Price to Earnings Ratio14.99-14.99-39.36--2.18--13.55-
Price-to-Total Gains Ratio14.85-14.85-159.44-21.91-43.27-
Price to Book Ratio3.03-3.03-3.17-3.55-4.55-
Price-to-Total Gains Ratio14.85-14.85-159.44-21.91-43.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.18243
Number of shares458
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.14-0.09
Usd Total Gains Per Share0.14-0.09
Gains per Quarter (458 shares)61.88-42.56
Gains per Year (458 shares)247.53-170.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102482380-170-180
204954860-340-350
307437340-511-520
409909820-681-690
50123812300-851-860
60148514780-1021-1030
70173317260-1192-1200
80198019740-1362-1370
90222822220-1532-1540
100247524700-1702-1710

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%7.013.04.029.2%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%9.015.00.037.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%3.00.021.012.5%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%9.015.00.037.5%

Fundamentals of Biohit Oyj B

About Biohit Oyj B

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company's diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; Biohit Active B12, a test for measuring the levels of active vitamin B12; BIOHIT Total 25OH Vitamin D, a test for determination of vitamin D status; and Biohit Calprotectin test for measuring human calprotectin. It also offers GastroPanel quick test NT, a quantitative immunochromatographic test for the detection of Helicobacter pylori (H. Pylori) and atrophic gastritis; BIOHIT Celiac Quick test for diagnosis of celiac disease; Biohit ColonView Quick test, a test for detection of fecal occult blood; Biohit Helicobacter Pylori UFT300 and Helicobacter Pylori Quick test methods to detect H. pylori infection; and Lactose Intolerance quick test to support the diagnosis of lactose intolerance in a duodenal biopsy specimen. In addition, the company provides acetaldehyde-binding products, such as Acetium capsules that are intended for persons with a low-acid or anacidic stomach; and Acetium lozenge, which helps in quitting smoking; and monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research. The company was incorporated in 1988 and is headquartered in Helsinki, Finland.

Fundamental data was last updated by Penke on 2024-04-19 16:49:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Biohit Oyj B.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biohit Oyj B earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Biohit Oyj B to the Biotechnology industry mean.
  • A Net Profit Margin of 14.5% means that €0.15 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biohit Oyj B:

  • The MRQ is 14.5%. The company is making a huge profit. +2
  • The TTM is 14.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.5%TTM14.5%0.0%
TTM14.5%YOY5.5%+9.0%
TTM14.5%5Y-11.3%+25.8%
5Y-11.3%10Y-12.5%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.5%-199.6%+214.1%
TTM14.5%-213.0%+227.5%
YOY5.5%-279.3%+284.8%
5Y-11.3%-438.4%+427.1%
10Y-12.5%-605.5%+593.0%
1.1.2. Return on Assets

Shows how efficient Biohit Oyj B is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biohit Oyj B to the Biotechnology industry mean.
  • 14.7% Return on Assets means that Biohit Oyj B generated €0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biohit Oyj B:

  • The MRQ is 14.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 14.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ14.7%TTM14.7%0.0%
TTM14.7%YOY5.5%+9.3%
TTM14.7%5Y-6.9%+21.6%
5Y-6.9%10Y-7.2%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7%-13.5%+28.2%
TTM14.7%-12.9%+27.6%
YOY5.5%-11.8%+17.3%
5Y-6.9%-14.1%+7.2%
10Y-7.2%-16.0%+8.8%
1.1.3. Return on Equity

Shows how efficient Biohit Oyj B is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biohit Oyj B to the Biotechnology industry mean.
  • 20.2% Return on Equity means Biohit Oyj B generated €0.20 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biohit Oyj B:

  • The MRQ is 20.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 20.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.2%TTM20.2%0.0%
TTM20.2%YOY8.1%+12.2%
TTM20.2%5Y-8.0%+28.2%
5Y-8.0%10Y-8.6%+0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.2%-16.9%+37.1%
TTM20.2%-16.1%+36.3%
YOY8.1%-15.1%+23.2%
5Y-8.0%-19.9%+11.9%
10Y-8.6%-20.9%+12.3%

1.2. Operating Efficiency of Biohit Oyj B.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biohit Oyj B is operating .

  • Measures how much profit Biohit Oyj B makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biohit Oyj B to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biohit Oyj B:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY7.9%-7.9%
TTM-5Y-13.0%+13.0%
5Y-13.0%10Y-30.4%+17.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY7.9%-288.4%+296.3%
5Y-13.0%-477.4%+464.4%
10Y-30.4%-625.6%+595.2%
1.2.2. Operating Ratio

Measures how efficient Biohit Oyj B is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.21 means that the operating costs are €1.21 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biohit Oyj B:

  • The MRQ is 1.214. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.214. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.214TTM1.2140.000
TTM1.214YOY0.897+0.317
TTM1.2145Y1.171+0.042
5Y1.17110Y1.324-0.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2143.090-1.876
TTM1.2143.264-2.050
YOY0.8973.783-2.886
5Y1.1715.679-4.508
10Y1.3247.894-6.570

1.3. Liquidity of Biohit Oyj B.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biohit Oyj B is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.81 means the company has €3.81 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biohit Oyj B:

  • The MRQ is 3.806. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.806. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.806TTM3.8060.000
TTM3.806YOY3.459+0.347
TTM3.8065Y4.257-0.450
5Y4.25710Y5.831-1.575
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8063.914-0.108
TTM3.8064.220-0.414
YOY3.4595.388-1.929
5Y4.2576.045-1.788
10Y5.8316.406-0.575
1.3.2. Quick Ratio

Measures if Biohit Oyj B is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biohit Oyj B to the Biotechnology industry mean.
  • A Quick Ratio of 2.39 means the company can pay off €2.39 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biohit Oyj B:

  • The MRQ is 2.387. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.387. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.387TTM2.3870.000
TTM2.387YOY4.008-1.621
TTM2.3875Y5.440-3.053
5Y5.44010Y8.725-3.285
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3873.572-1.185
TTM2.3873.998-1.611
YOY4.0085.390-1.382
5Y5.4405.969-0.529
10Y8.7256.287+2.438

1.4. Solvency of Biohit Oyj B.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biohit Oyj B assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biohit Oyj B to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.27 means that Biohit Oyj B assets are financed with 27.1% credit (debt) and the remaining percentage (100% - 27.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biohit Oyj B:

  • The MRQ is 0.271. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.271. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.271TTM0.2710.000
TTM0.271YOY0.323-0.052
TTM0.2715Y0.238+0.034
5Y0.23810Y0.181+0.057
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2710.336-0.065
TTM0.2710.334-0.063
YOY0.3230.269+0.054
5Y0.2380.366-0.128
10Y0.1810.390-0.209
1.4.2. Debt to Equity Ratio

Measures if Biohit Oyj B is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biohit Oyj B to the Biotechnology industry mean.
  • A Debt to Equity ratio of 37.2% means that company has €0.37 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biohit Oyj B:

  • The MRQ is 0.372. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.372. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.372TTM0.3720.000
TTM0.372YOY0.477-0.105
TTM0.3725Y0.319+0.053
5Y0.31910Y0.231+0.088
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3720.382-0.010
TTM0.3720.396-0.024
YOY0.4770.335+0.142
5Y0.3190.434-0.115
10Y0.2310.465-0.234

2. Market Valuation of Biohit Oyj B

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Biohit Oyj B generates.

  • Above 15 is considered overpriced but always compare Biohit Oyj B to the Biotechnology industry mean.
  • A PE ratio of 14.99 means the investor is paying €14.99 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biohit Oyj B:

  • The EOD is 16.307. Based on the earnings, the company is fair priced.
  • The MRQ is 14.994. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.994. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD16.307MRQ14.994+1.312
MRQ14.994TTM14.9940.000
TTM14.994YOY39.356-24.361
TTM14.9945Y-2.180+17.174
5Y-2.18010Y-13.554+11.374
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.307-2.259+18.566
MRQ14.994-2.569+17.563
TTM14.994-2.664+17.658
YOY39.356-4.120+43.476
5Y-2.180-6.258+4.078
10Y-13.554-6.171-7.383
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biohit Oyj B:

  • The EOD is 44.261. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 40.699. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 40.699. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD44.261MRQ40.699+3.562
MRQ40.699TTM40.6990.000
TTM40.699YOY13.221+27.477
TTM40.6995Y85.171-44.472
5Y85.17110Y-11.380+96.551
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD44.261-2.924+47.185
MRQ40.699-3.246+43.945
TTM40.699-3.488+44.187
YOY13.221-5.620+18.841
5Y85.171-8.315+93.486
10Y-11.380-8.826-2.554
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biohit Oyj B is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.03 means the investor is paying €3.03 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biohit Oyj B:

  • The EOD is 3.296. Based on the equity, the company is fair priced.
  • The MRQ is 3.031. Based on the equity, the company is fair priced.
  • The TTM is 3.031. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.296MRQ3.031+0.265
MRQ3.031TTM3.0310.000
TTM3.031YOY3.171-0.141
TTM3.0315Y3.546-0.515
5Y3.54610Y4.550-1.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.2961.851+1.445
MRQ3.0312.090+0.941
TTM3.0312.095+0.936
YOY3.1712.844+0.327
5Y3.5463.466+0.080
10Y4.5503.815+0.735
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biohit Oyj B compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1270.1270%0.010+1189%-0.087+169%-0.099+178%
Book Value Per Share--0.6220.6220%0.495+26%0.630-1%0.765-19%
Current Ratio--3.8063.8060%3.459+10%4.257-11%5.831-35%
Debt To Asset Ratio--0.2710.2710%0.323-16%0.238+14%0.181+50%
Debt To Equity Ratio--0.3720.3720%0.477-22%0.319+17%0.231+61%
Dividend Per Share----0%-0%-0%0.069-100%
Eps--0.1260.1260%0.040+215%-0.050+140%-0.048+138%
Free Cash Flow Per Share--0.0460.0460%0.119-61%0.027+74%-0.061+232%
Free Cash Flow To Equity Per Share--0.0460.0460%0.106-56%0.018+164%-0.124+369%
Gross Profit Margin--1.0001.0000%0.255+293%1.076-7%1.225-18%
Intrinsic Value_10Y_max--2.172--------
Intrinsic Value_10Y_min---0.054--------
Intrinsic Value_1Y_max--0.082--------
Intrinsic Value_1Y_min---0.048--------
Intrinsic Value_3Y_max--0.350--------
Intrinsic Value_3Y_min---0.107--------
Intrinsic Value_5Y_max--0.742--------
Intrinsic Value_5Y_min---0.127--------
Market Cap24883105.000-14%28489122.80528489122.8050%23652813.020+20%33496263.940-15%50817753.419-44%
Net Profit Margin--0.1450.1450%0.055+164%-0.113+178%-0.125+186%
Operating Margin----0%0.079-100%-0.1300%-0.3040%
Operating Ratio--1.2141.2140%0.897+35%1.171+4%1.324-8%
Pb Ratio3.296+8%3.0313.0310%3.171-4%3.546-15%4.550-33%
Pe Ratio16.307+8%14.99414.9940%39.356-62%-2.180+115%-13.554+190%
Price Per Share2.050+8%1.8851.8850%1.570+20%2.226-15%3.409-45%
Price To Free Cash Flow Ratio44.261+8%40.69940.6990%13.221+208%85.171-52%-11.380+128%
Price To Total Gains Ratio16.152+8%14.85214.8520%159.441-91%21.912-32%43.274-66%
Quick Ratio--2.3872.3870%4.008-40%5.440-56%8.725-73%
Return On Assets--0.1470.1470%0.055+170%-0.069+147%-0.072+149%
Return On Equity--0.2020.2020%0.081+151%-0.080+140%-0.086+143%
Total Gains Per Share--0.1270.1270%0.010+1189%-0.087+169%-0.030+124%
Usd Book Value--10007240.00010007240.0000%7939786.800+26%10101137.720-1%12169761.980-18%
Usd Book Value Change Per Share--0.1350.1350%0.010+1189%-0.093+169%-0.106+178%
Usd Book Value Per Share--0.6620.6620%0.527+26%0.671-1%0.815-19%
Usd Dividend Per Share----0%-0%-0%0.073-100%
Usd Eps--0.1340.1340%0.042+215%-0.053+140%-0.051+138%
Usd Free Cash Flow--745220.000745220.0000%1904569.400-61%427756.280+74%-954626.820+228%
Usd Free Cash Flow Per Share--0.0490.0490%0.126-61%0.028+74%-0.065+232%
Usd Free Cash Flow To Equity Per Share--0.0490.0490%0.113-56%0.019+164%-0.132+369%
Usd Market Cap26490553.583-14%30329520.13830329520.1380%25180784.741+20%35660122.591-15%54100580.290-44%
Usd Price Per Share2.182+8%2.0072.0070%1.671+20%2.370-15%3.629-45%
Usd Profit--2022740.0002022740.0000%639824.600+216%-793552.840+139%-756291.840+137%
Usd Revenue--13946260.00013946260.0000%11658434.600+20%10770984.040+29%9379764.760+49%
Usd Total Gains Per Share--0.1350.1350%0.010+1189%-0.093+169%-0.032+124%
 EOD+2 -6MRQTTM+0 -0YOY+23 -115Y+19 -1410Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Biohit Oyj B based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.307
Price to Book Ratio (EOD)Between0-13.296
Net Profit Margin (MRQ)Greater than00.145
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.387
Current Ratio (MRQ)Greater than13.806
Debt to Asset Ratio (MRQ)Less than10.271
Debt to Equity Ratio (MRQ)Less than10.372
Return on Equity (MRQ)Greater than0.150.202
Return on Assets (MRQ)Greater than0.050.147
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Biohit Oyj B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.934
Ma 20Greater thanMa 502.014
Ma 50Greater thanMa 1001.965
Ma 100Greater thanMa 2001.933
OpenGreater thanClose2.050
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets12,900
Total Liabilities3,500
Total Stockholder Equity9,400
 As reported
Total Liabilities 3,500
Total Stockholder Equity+ 9,400
Total Assets = 12,900

Assets

Total Assets12,900
Total Current Assets11,800
Long-term Assets1,100
Total Current Assets
Cash And Cash Equivalents 3,000
Short-term Investments 3,300
Net Receivables 4,100
Inventory 900
Other Current Assets 500
Total Current Assets  (as reported)11,800
Total Current Assets  (calculated)11,800
+/-0
Long-term Assets
Property Plant Equipment 700
Long-term Assets Other 100
Long-term Assets  (as reported)1,100
Long-term Assets  (calculated)800
+/- 300

Liabilities & Shareholders' Equity

Total Current Liabilities3,100
Long-term Liabilities400
Total Stockholder Equity9,400
Total Current Liabilities
Accounts payable 500
Other Current Liabilities 1,900
Total Current Liabilities  (as reported)3,100
Total Current Liabilities  (calculated)2,400
+/- 700
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt700
Long-term Liabilities  (as reported)400
Long-term Liabilities  (calculated)700
+/- 300
Total Stockholder Equity
Retained Earnings 3,800
Total Stockholder Equity (as reported)9,400
Total Stockholder Equity (calculated)3,800
+/- 5,600
Other
Capital Stock2,400
Common Stock Shares Outstanding 15,114
Net Invested Capital 9,400
Net Working Capital 8,700
Property Plant and Equipment Gross 700



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
146,417
24,995
22,414
21,875
22,759
27,851
27,320
27,338
27,107
27,399
29,383
71,472
40,007
28,302
14,508
11,728
12,989
18,895
17,887
17,372
10,777
9,613
11,015
12,900
12,90011,0159,61310,77717,37217,88718,89512,98911,72814,50828,30240,00771,47229,38327,39927,10727,33827,32027,85122,75921,87522,41424,995146,417
   > Total Current Assets 
0
0
0
0
10,207
14,852
14,141
14,040
14,359
14,006
15,177
64,216
31,531
24,062
12,011
8,875
10,586
11,354
12,229
13,213
8,299
8,984
9,900
11,800
11,8009,9008,9848,29913,21312,22911,35410,5868,87512,01124,06231,53164,21615,17714,00614,35914,04014,14114,85210,2070000
       Cash And Cash Equivalents 
17,933
2,457
1,374
1,054
1,296
1,745
850
1,109
1,310
1,580
1,659
47,915
248
467
608
723
597
1,339
1,375
1,325
1,038
1,102
2,122
3,000
3,0002,1221,1021,0381,3251,3751,33959772360846724847,9151,6591,5801,3101,1098501,7451,2961,0541,3742,45717,933
       Short-term Investments 
0
0
0
0
-4
2,400
856
923
480
400
500
10,000
30,233
15,239
9,810
6,518
7,134
7,375
8,003
7,996
5,041
4,413
4,105
3,300
3,3004,1054,4135,0417,9968,0037,3757,1346,5189,81015,23930,23310,0005004004809238562,400-40000
       Net Receivables 
30,949
4,837
4,924
5,419
4,977
6,122
6,346
6,385
6,800
6,339
7,779
5,649
422
7,677
774
998
1,991
1,617
1,655
2,902
1,317
2,721
1,140
4,100
4,1001,1402,7211,3172,9021,6551,6171,9919987747,6774225,6497,7796,3396,8006,3856,3466,1224,9775,4194,9244,83730,949
       Other Current Assets 
7,419
2,010
1,735
1,446
5,346
1
6,664
1
480
6,888
1
5,982
606
33
3
-1
1,991
-1
-1
0
0
-2
0
500
5000-200-1-11,991-13336065,98216,88848016,66415,3461,4461,7352,0107,419
   > Long-term Assets 
0
0
0
0
12,552
12,999
13,179
13,298
12,748
13,393
14,206
7,256
8,476
4,240
2,497
2,853
2,403
7,541
5,657
4,159
2,478
629
1,115
1,100
1,1001,1156292,4784,1595,6577,5412,4032,8532,4974,2408,4767,25614,20613,39312,74813,29813,17912,99912,5520000
       Property Plant Equipment 
33,569
6,370
6,425
6,195
6,802
6,860
6,855
7,203
6,452
6,460
6,531
116
432
506
857
782
716
708
557
672
640
420
993
700
7009934206406725577087167828575064321166,5316,4606,4527,2036,8556,8606,8026,1956,4256,37033,569
       Goodwill 
27,477
3,671
3,049
2,638
2,638
2,638
2,638
2,638
2,638
2,638
2,638
0
0
25
0
0
0
0
0
0
0
0
0
0
000000000025002,6382,6382,6382,6382,6382,6382,6382,6383,0493,67127,477
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,002
0
596
381
0
1
58
0
0
0
0
0000581038159601,0020000000000000
       Intangible Assets 
30,703
4,247
3,673
3,263
1,160
1,419
1,576
1,494
1,636
2,349
3,177
311
223
1,733
1,609
1,396
1,196
6,763
5,045
3,400
1,763
137
42
0
0421371,7633,4005,0456,7631,1961,3961,6091,7332233113,1772,3491,6361,4941,5761,4191,1603,2633,6734,24730,703
       Long-term Assets Other 
0
0
0
0
-1
2,404
856
923
12
400
499
-1
37,045
15,232
-3
6,520
7,137
1
8,003
7,997
5,041
4,413
4,105
100
1004,1054,4135,0417,9978,00317,1376,520-315,23237,045-1499400129238562,404-10000
> Total Liabilities 
48,394
8,661
7,518
7,774
8,620
13,601
13,905
15,496
14,615
14,650
16,380
18,626
4,515
5,852
1,831
1,418
2,239
1,652
1,995
2,792
2,074
2,313
3,557
3,500
3,5003,5572,3132,0742,7921,9951,6522,2391,4181,8315,8524,51518,62616,38014,65014,61515,49613,90513,6018,6207,7747,5188,66148,394
   > Total Current Liabilities 
24,427
5,234
3,636
4,124
4,063
5,068
6,479
6,172
5,822
10,005
6,980
18,536
4,515
5,644
1,628
1,239
1,822
1,278
1,569
2,377
1,940
2,149
2,862
3,100
3,1002,8622,1491,9402,3771,5691,2781,8221,2391,6285,6444,51518,5366,98010,0055,8226,1726,4795,0684,0634,1243,6365,23424,427
       Short-term Debt 
0
0
0
0
917
901
1,383
866
1,098
5,118
920
4,906
384
384
256
128
0
17
17
228
256
66
257
0
025766256228171701282563843844,9069205,1181,0988661,3839019170000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
384
256
128
0
76
0
0
0
0
0
0
0000007601282563840000000000000
       Accounts payable 
5,771
1,246
837
1,287
1,135
1,676
1,798
1,419
1,321
1,409
1,854
3,045
362
341
529
326
979
414
518
869
612
577
676
500
5006765776128695184149793265293413623,0451,8541,4091,3211,4191,7981,6761,1351,2878371,2465,771
       Other Current Liabilities 
13,406
3,192
1,998
1,909
2,011
2,491
3,106
3,704
3,403
3,478
4,156
6,057
3,769
1
789
785
843
839
1,021
2
-28
54
1,929
1,900
1,9001,92954-2821,02183984378578913,7696,0574,1563,4783,4033,7043,1062,4912,0111,9091,9983,19213,406
   > Long-term Liabilities 
0
0
0
0
4,557
8,533
7,426
9,324
8,793
4,645
9,400
90
0
208
203
179
417
374
426
415
134
164
695
400
4006951641344154263744171792032080909,4004,6458,7939,3247,4268,5334,5570000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125
155
686
0
068615512500000000000000000000
       Other Liabilities 
0
0
815
680
593
1,181
1,014
981
801
790
818
0
0
209
3
179
417
315
384
356
3
2
2
0
02233563843154171793209008187908019811,0141,18159368081500
> Total Stockholder Equity
97,732
16,223
14,821
14,036
14,139
14,250
13,415
11,842
12,492
12,749
13,003
52,846
35,492
22,450
12,676
10,310
10,750
17,243
15,892
14,579
8,703
7,299
7,457
9,400
9,4007,4577,2998,70314,57915,89217,24310,75010,31012,67622,45035,49252,84613,00312,74912,49211,84213,41514,25014,13914,03614,82116,22397,732
   Common Stock
12,780
2,149
2,199
2,199
2,199
2,199
2,199
2,199
2,199
2,199
2,199
2,315
2,315
2,348
2,350
2,350
2,350
2,350
2,350
2,350
2,350
2,350
2,350
0
02,3502,3502,3502,3502,3502,3502,3502,3502,3502,3482,3152,3152,1992,1992,1992,1992,1992,1992,1992,1992,1992,14912,780
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,138
5,138
5,138
0
05,1385,1385,13800000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
13,067
13,137
12,528
12,457
12,210
12,080
12,273
14,291
3,226
2,755
1,887
2,379
4,254
4,634
4,782
5,054
3,885
3,970
3,330
0
03,3303,9703,8855,0544,7824,6344,2542,3791,8872,7553,22614,29112,27312,08012,21012,45712,52813,13713,0670000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue13,100
Cost of Revenue-4,600
Gross Profit8,5008,500
 
Operating Income (+$)
Gross Profit8,500
Operating Expense-11,300
Operating Income1,800-2,800
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense11,3000
 
Net Interest Income (+$)
Interest Income500
Interest Expense-200
Other Finance Cost-0
Net Interest Income300
 
Pretax Income (+$)
Operating Income1,800
Net Interest Income300
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,2001,800
EBIT - interestExpense = -200
1,900
2,100
Interest Expense200
Earnings Before Interest and Taxes (EBIT)-2,400
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax2,200
Tax Provision-300
Net Income From Continuing Ops1,9001,900
Net Income1,900
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--300
 

Technical Analysis of Biohit Oyj B
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biohit Oyj B. The general trend of Biohit Oyj B is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biohit Oyj B's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biohit Oyj B.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.09 < 2.09 < 2.09.

The bearish price targets are: 1.99 > 1.89 > 1.885.

Tweet this
Biohit Oyj B Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biohit Oyj B. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biohit Oyj B Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biohit Oyj B. The current macd is 0.03019735.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biohit Oyj B price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biohit Oyj B. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biohit Oyj B price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biohit Oyj B Daily Moving Average Convergence/Divergence (MACD) ChartBiohit Oyj B Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biohit Oyj B. The current adx is 37.22.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biohit Oyj B shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Biohit Oyj B Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biohit Oyj B. The current sar is 2.093384.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biohit Oyj B Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biohit Oyj B. The current rsi is 61.93. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Biohit Oyj B Daily Relative Strength Index (RSI) ChartBiohit Oyj B Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biohit Oyj B. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biohit Oyj B price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biohit Oyj B Daily Stochastic Oscillator ChartBiohit Oyj B Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biohit Oyj B. The current cci is 34.49.

Biohit Oyj B Daily Commodity Channel Index (CCI) ChartBiohit Oyj B Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biohit Oyj B. The current cmo is 24.18.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Biohit Oyj B Daily Chande Momentum Oscillator (CMO) ChartBiohit Oyj B Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biohit Oyj B. The current willr is -43.47826087.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biohit Oyj B is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biohit Oyj B Daily Williams %R ChartBiohit Oyj B Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biohit Oyj B.

Biohit Oyj B Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biohit Oyj B. The current atr is 0.05075581.

Biohit Oyj B Daily Average True Range (ATR) ChartBiohit Oyj B Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biohit Oyj B. The current obv is 507,307.

Biohit Oyj B Daily On-Balance Volume (OBV) ChartBiohit Oyj B Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biohit Oyj B. The current mfi is 57.06.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biohit Oyj B Daily Money Flow Index (MFI) ChartBiohit Oyj B Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biohit Oyj B.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Biohit Oyj B Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biohit Oyj B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.934
Ma 20Greater thanMa 502.014
Ma 50Greater thanMa 1001.965
Ma 100Greater thanMa 2001.933
OpenGreater thanClose2.050
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biohit Oyj B with someone you think should read this too:
  • Are you bullish or bearish on Biohit Oyj B? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biohit Oyj B? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biohit Oyj B

I send you an email if I find something interesting about Biohit Oyj B.


Comments

How you think about this?

Leave a comment

Stay informed about Biohit Oyj B.

Receive notifications about Biohit Oyj B in your mailbox!